Regeneron Pharmaceuticals, Inc.
N-TERMINAL scFv MULTISPECIFIC BINDING MOLECULES

Last updated:

Abstract:

Multispecific binding molecules (MBMs) comprising an N-terminal scFv, a first Fab and a second Fab, MBM conjugates comprising the MBMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the MBMs and MBM conjugates, methods of using the MBMs, MBM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the MBMs, cells engineered to express the MBMs, and methods of producing MBMs.

Status:
Application
Type:

Utility

Filling date:

4 Nov 2020

Issue date:

6 May 2021